|
Infosys Technologies
A company that adds an organization equivalent to half its size every year poses a very stiff challenge to those reclusive strategists-the board of directories.With annual growth revenue of $1 billion plus,the board of directories include N.R. Narayana Murthy,Nandan Nilekani,Omkar Goswami,Larry pressler and Claude Smadja.
Infosys Technologies Ltd. provides consulting and IT services to clients globally - as partners to conceptualize and realize technology driven business transformation initiatives. With over 58,000 employees worldwide, we use a low-risk Global Delivery Model (GDM) to accelerate schedules with a high degree of time and cost predictability.
As one of the pioneers in strategic offshore outsourcing of software services, Infosys has leveraged the global trend of offshore outsourcing. Even as many software outsourcing companies were blamed for diverting global jobs to cheaper offshore outsourcing destinations like India and China, Infosys was recently applauded by Wired magazine for its unique offshore outsourcing strategy ?? it singled out Infosys for turning the outsourcing myth around and bringing jobs back to the US.
Reliance Industries
Dhirubhai Ambani founded Reliance as a textile company and led its evolution as a global leader in the materials and energy value chain businesses. He is credited to have brought about the equity cult in India in the late seventies and is regarded as an icon for enterprise in India. He epitomized the spirit 'dare to dream and learn to excel'.
Today Mukesh Ambani,chairman of the India??s biggest private sector company. By investing Rs 10,500 crore at one go in Reliance Infocomm,the group??s telecom venture,has proved that Reliance can pull off big projects-not just in petrochemicals,but also in any other field it lays hands on.
In just one year after its launch, Reliance Infocomm has garnered 7 million subscribers for its mobile telephone services.Its services are now available in more cities and towns than any competitor,baring the state owned Bharat Sanchar Nigam which has been in the business for than four decades.
Wipro
Azim Premji,chairman of Wipro says continuing to believe in our long term strategy ,building a complete range of IT and BPO solutions for our customers,deep engagement in R&D services and technology domain and significant leverage from our India Business.
Premji says he will not easily forget the hammering Wipro received from analysts when it entered the BPO space buyout of spectramind in july 2002.Wipro??s entire focuss is now on getting the organization ready to handle huge IT outsourcing deals-perhaps in excess of hundreds of millions of dollars.
Hindustan Lever
Hindustan Lever Limited (also called HLL) is India's largest consumer products company and is headquartered in Mumbai. Lever Brothers India Limited was formed in 1933 which became Hindustan Lever Limited. It has 41,000 employees. HLL is the market leader in Indian products such as tea, soaps, detergents. As of May 2006, it is headed by Mr Douglas Bailey.
Hind Lever's water debut in Jan Consumer foods giant Hindustan Lever will launch its water business in January 2004. The foray was significant for Hindustan Lever because its British parent, Unilever Plc, was likely to go in for a global launch of the water business in select markets if the experiment turned out to be successful in India, Hindustan Lever executives said.
The company has ruled out its entry through the "purified water in bottles" line, and is looking at tapping the purified water dispensers market by targeting the household sector, a market that is estimated at around Rs 200 crore (Rs 2 billion).
The equipment would provide purified water much cheaper to domestic consumers, compared with bottled water, Hindustan Lever sources said.
With Hindustan Lever entering the water business, the competition is expected to heat up in the domestic market.
Maruti Udyog
Maruti Udyog Limited (MUL) was established in Feb 1981 through an Act of Parliament, to meet the growing demand of a personal mode of transport caused by the lack of an efficient public transport system.
Suzuki Motor Company was chosen from seven prospective partners worldwide. This was due not only to their undisputed leadership in small cars but also to their commitment to actively bring to MUL contemporary technology and Japanese management practices (which had catapulted Japan over USA to the status of the top auto manufacturing country in the world).
A licence and a Joint Venture agreement was signed between Govt of India and Suzuki Motor Company (now Suzuki Motor Corporation of Japan) in Oct 1982
As opposed to marketshare,opportunities share-as conceived by Maruti Udyog??s managing director Jagdish Khattar ?ˇěC Is the portion of business that a company captures from new opportunities which the company itself creates. Khattar believes that all market leaders must concentrate more on creating fundamentally new opportunities and grabbing a larger share of business from those than existing market.
DR.Reddy??s Lab
Dr. Reddy??s Laboratories was founded by Dr Anji Reddy, a entrepreneur-scientist, in 1984. The DNA of the company is drawn from its founder and his vision to establish India??s first discovery led global pharmaceutical company. In fact, it is this spirit of entrepreneurship that has shaped the company to become what it is today.
Dr Anji Reddy, having moved out of Standard Organics Limited, a company he had successfully co-founded, started Dr. Reddy??s Laboratories with $ 40,000 in cash and $120,000 in bank loan! Today, the company with revenues of Rs.1947 crore (US $446 million), as of fiscal year 2005, is India??s second largest pharmaceutical company and the youngest among its peer group.
The company has several distinctions to its credit. Being the first pharmaceutical company from Asia Pacific (outside Japan) to be listed on the New York Stock Exchange (on April 11, 2001) is only one among them. And as always, Dr. Reddy??s chose to do it in the most difficult of circumstances against widespread skepticism. Dr. Reddy??s came up trumps not only having its stock oversubscribed but also becoming the best performing IPO that year.
Dr. Anji Reddy is well known for his passion for research and drug discovery. Dr. Reddy??s started its drug discovery programme in 1993 and within three years it achieved its first breakthrough by outlicensing an anti-diabetes molecule to Novo Nordisk in March 1997. With this very small but significant step, the Indian industry went through a paradigm shift in its image from being known as just ??copycats?? to ??innovators??! Through its success, Dr. Reddy??s pioneered drug discovery in India. There are several
such inflection points in the company??s evolution from a bulk drug (API) manufacturer into a vertically integrated global pharmaceutical company today.
Today, the company manufactures and markets API (Bulk Actives), Finished Dosages and Biologics in over 100 countries worldwide, in addition to having a very promising Drug Discovery Pipeline. When Dr. Reddy??s started its first big move in 1986 from manufacturing and marketing bulk actives to the domestic (Indian) market to manufacturing and exporting difficult-to-manufacture bulk actives such as Methyldopa to highly regulated overseas markets, it had to not only overcome regulatory and legal hurdles but also battle deeply entrenched mind-set issues of Indian Pharma being seen as producers of 'cheap' and therefore ??low quality?? pharmaceuticals. Today, the Indian pharma industry, in stark contrast, is known globally for its proven high quality-low cost advantage in delivering safe and effective pharmaceuticals. This transition, a tough and often-perilous one, was made possible thanks to the pioneering efforts of companies such as Dr. Reddy??s.
|
